NEU 0.62% $13.02 neuren pharmaceuticals limited

Katelin’s Turn is HERE!!!, page-40

  1. 53 Posts.
    lightbulb Created with Sketch. 55
    If I recall correctly, in the Phase 2 trial Katelin was a part of there were two drug cohorts plus placebo. Half of the participants receiving the drug were on a lower dose of 35mcg/kg during the trial and the other half on 70 mcg/kg.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.